Svetlana Gingis-Velitski

Title: Svetlana Gingis-Velitski: Innovator in Biomedicine

Introduction

Svetlana Gingis-Velitski is a prominent inventor based in Kiryat Motzkin, Israel. She has made significant contributions to the field of biomedicine, particularly in the development of innovative therapeutic methods. With a total of 3 patents to her name, her work focuses on the creation of chimeric polypeptides and their applications in treating various medical conditions.

Latest Patents

Svetlana's latest patents include groundbreaking research on chimeric polypeptides and polynucleotides encoding the same. One of her notable inventions involves a plant-produced chimeric polypeptide, which has potential therapeutic applications. Additionally, she has developed a method for treating TNF Alpha associated medical conditions, such as obesity, metabolic syndrome, diabetes, and liver diseases. This method involves the enteral administration of plant cells expressing a TNF Alpha polypeptide inhibitor, providing a novel approach to treatment.

Career Highlights

Throughout her career, Svetlana has worked with several esteemed organizations, including Protalix Ltd. and Hadasit Medical Research Services and Development Ltd. Her expertise in biomedicine has allowed her to contribute to significant advancements in therapeutic techniques and methodologies.

Collaborations

Svetlana has collaborated with notable colleagues in her field, including Yoseph Shaaltiel and Uri Hanania. These partnerships have further enhanced her research and development efforts, leading to innovative solutions in medical treatments.

Conclusion

Svetlana Gingis-Velitski is a trailblazer in the field of biomedicine, with a focus on developing innovative therapies through her patented inventions. Her contributions continue to impact the medical community positively.